Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2022-02-14 3:09 pm Sale | 13G | AMBRX BIOPHARMA INC SPONSORED AMAM | Cormorant Asset Management LP | 17,266,144 7.06% | -138,558 (-0.80%) | View |
| 2022-02-11 4:03 pm Sale | 13G | AMBRX BIOPHARMA INC SPONSORED AMAM | HBM Healthcare Investments (Cayman) Ltd. | 16,856,567 6.9% | -898,156 (-5.06%) | View |
| 2022-02-09 09:09 am Purchase | 13G | AMBRX BIOPHARMA INC SPONSORED AMAM | FMR LLC | 26,985,175 9.996% | 26,985,175 (New Position) | View |
| 2022-02-08 4:01 pm Purchase | 13G | AMBRX BIOPHARMA INC SPONSORED AMAM | WuXi PharmaTech Healthcare Fund I L.P. | 29,267,687 12% | 29,267,687 (New Position) | View |
| 2022-01-18 4:30 pm Purchase | 13G | AMBRX BIOPHARMA INC SPONSORED AMAM | ADAGE CAPITAL PARTNERS GP L.L.C. | 14,191,037 5.8% | 14,191,037 (New Position) | View |
| 2021-07-12 4:56 pm Purchase | 13G | AMBRX BIOPHARMA INC SPONSORED AMAM | Artal International S.C.A. | 15,066,043 5.7% | 15,066,043 (New Position) | View |
| 2021-07-02 4:12 pm Purchase | 13G | AMBRX BIOPHARMA INC SPONSORED AMAM | Cormorant Asset Management LP | 17,404,702 6.6% | 17,404,702 (New Position) | View |
| 2021-07-02 4:00 pm Purchase | 13G | AMBRX BIOPHARMA INC SPONSORED AMAM | HBM Healthcare Investments (Cayman) Ltd. | 17,754,723 6.7% | 17,754,723 (New Position) | View |